Abstract: An aminopyridine compound that may be used as an aldehyde trapping agent, and specifically disclosed is a compound represented by formula (I) and a pharmaceutically acceptable salt thereof.

Abstract: A pyrimidine ring compound represented by formula (III), or a pharmaceutically acceptable salt thereof, and an application thereof in preparation of a medication for treating related diseases.

Abstract: Provided are a class of pyridone multiple-membered ring derivatives and the use thereof. Specifically provided are a compound as represented by formula (VI) and a pharmaceutically acceptable salt thereof.

Abstract: Provided is an aldehyde binder, specifically, disclosed is a compound as represented by formula (II) or a pharmaceutically acceptable salt.

Abstract: A speech recognition method is provided. The method includes: obtaining a to-be-recognized speech and a speech recognition model, including an encoding network and a decoding network, after training; during each stage of encoding the to-be-recognized speech using the encoding network, classifying the to-be-recognized speech under a target speech attribute to obtain a predicted attribute category, and performing encoding to obtain a first encoding feature according to the predicted attribute category under the target speech attribute; decoding the first encoding feature according to the decoding network to obtain a recognition text of the to-be-recognized speech, the speech recognition model being adjusted according to at least a first loss, which represents a difference between a preset attribute category annotated in a speech sample and a sample attribute category recognized and obtained by the speech recognition model under the target speech attribute.

Abstract: A crystal form of a pyridinylphenyl compound and a preparation method therefor. Use of the crystal form in the preparation of a medicament of treating related diseases is also comprised.

Abstract: A novel indazole compound, a preparation method therefor, and use thereof in the preparation of drugs for treating related diseases. Specifically disclosed are a compound of formula (II) and a pharmaceutically acceptable salt thereof.

Abstract: The present invention relates to a pyrrolopyrimidine compound used as a JAK inhibitor, and the use thereof in the preparation of a drug for treating a JAK1- and/or JAK2-associated disease, and in specifically relates to a compound represented by formula (I), an isomer thereof or a pharmaceutically acceptable salt thereof.

Abstract: A method for constructing a decoding network, a speech recognition method, a device, an apparatus, and a storage medium are provided. The method for constructing a decoding network includes: acquiring a general language model, a domain language model, and a general decoding network generated based on the general language model; generating a domain decoding network based on the domain language model and the general language model; and integrating the domain decoding network with the general decoding network to obtain a target decoding network. The speech recognition method includes: decoding to-be-recognized speech data by using a target decoding network to obtain a decoding path for the to-be-recognized speech data; and determining a speech recognition result for the to-be-recognized speech data based on the decoding path for the to-be-recognized speech data.

Abstract: Provided is an indole compound. In particular, disclosed are a compound represented by formula (II) or an isomer or pharmaceutically acceptable salt thereof and a use of the same as an estrogen receptor antagonist in preparing a drug for treating estrogen receptor-positive breast cancer.

Abstract: A speech recognition error correction method and device, and a readable storage medium are provided. The method includes: acquiring to-be-recognized speech data and a first recognition result of the speech data, re-recognizing the speech data with reference to context information in the first recognition result to obtain a second recognition result, and determining a final recognition result based on the second recognition result. In the method, the speech data is re-recognized with reference to context information in the first recognition result, which fully considers context information in the recognition result and the application scenario of the speech data. If any error occurs in the first recognition result, the first recognition result is corrected based on the second recognition. Therefore, the accuracy of speech recognition can be improved.

Abstract: Preparation and application of a series of polypeptides, and specifically disclosed is a polypeptide having a sequence as shown in formula (II). YAibEGT FTSDY SIAibLD KIAQK AFVKW LIAGG PSSGA PPPS0??(II).

Abstract: Provided is an aldehyde binder, specifically, disclosed is a compound as represented by formula (II) or a pharmaceutically acceptable salt.

Abstract: Disclosed is an aminopyrimidine compound as a CDK2/4/6 inhibitor, and specifically disclosed are the compound represented by formula (I) and a pharmaceutically acceptable salt thereof, and an application of the compound represented by formula (I) and the pharmaceutically acceptable salt thereof in the preparation of a medicament for treating solid tumor.

Abstract: Disclosed in the present invention are a series of fused polycyclic substituted 5-carboxylic acid thienopyrimidine dione compounds and the use thereof. Specifically disclosed are a compound represented by formula (H) and a pharmaceutically acceptable salt thereof.

Abstract: A series of piperidine-substituted benzoic acid compounds and the use thereof, and specifically disclosed is a compound represented by formula (I) and a pharmaceutically acceptable salt thereof.

Abstract: Provided is an aldehyde binder, specifically, disclosed is a compound as represented by formula (II) or a pharmaceutically acceptable salt.

Abstract: Disclosed are a [1,2,4]triazolo[1,5-a]pyridine compound as JAK inhibitor and an application thereof in preparing a drug for treating a disease related to JAK1 or/and TYK2. Specifically, the present invention relates to a compound represented by formula (I), or an isomer or pharmaceutically acceptable salt thereof.

Abstract: A class of lactam-modified polypeptide compounds and the use thereof in the preparation of a drug for treating related diseases.